Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (281-290 of 590) with videos related to

Pageof 59
Sort By:
Oncotarget|May 19, 2016
Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemiaSandrine Poglio, Daniel Lewandowski, Julien Calvo, et al.
Pediatric Blood & Cancer|November 6, 2018
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218Rebecca J Deyell, Bing Wu, S Rod Rassekh, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
The Visible Cement Data SetDale P Bentz, Symoane Mizell, Steve Satterfield, et al.
Blood|April 10, 2009
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorderClaude Preudhomme, Aline Renneville, Violaine Bourdon, et al.
Contrast Media & Molecular Imaging|November 4, 2017
Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft ModelsLibo Zhang, Douglass C Vines, Deborah A Scollard, et al.
Pediatric Pulmonology|December 31, 2015
Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatmentLisa Giovannini-Chami, Sibylle Blanc, Alice Hadchouel, et al.
British Journal of Haematology|September 2, 2008
Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemiaBenoit Brethon, Karima Yakouben, Caroline Oudot, et al.
Nature Medicine|April 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Blood Advances|August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at DiagnosisMathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Pediatric Blood & Cancer|August 31, 2018
Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patientsMeinolf Suttorp, Markus Metzler, Frederic Millot, et al.
Pageof 59

Showing results (281-290 of 590) with videos related to

Sort By:
Pageof 59
Oncotarget|May 19, 2016
Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemiaSandrine Poglio, Daniel Lewandowski, Julien Calvo, et al.
Pediatric Blood & Cancer|November 6, 2018
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218Rebecca J Deyell, Bing Wu, S Rod Rassekh, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
The Visible Cement Data SetDale P Bentz, Symoane Mizell, Steve Satterfield, et al.
Blood|April 10, 2009
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorderClaude Preudhomme, Aline Renneville, Violaine Bourdon, et al.
Contrast Media & Molecular Imaging|November 4, 2017
Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft ModelsLibo Zhang, Douglass C Vines, Deborah A Scollard, et al.
Pediatric Pulmonology|December 31, 2015
Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatmentLisa Giovannini-Chami, Sibylle Blanc, Alice Hadchouel, et al.
British Journal of Haematology|September 2, 2008
Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemiaBenoit Brethon, Karima Yakouben, Caroline Oudot, et al.
Nature Medicine|April 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Blood Advances|August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at DiagnosisMathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Pediatric Blood & Cancer|August 31, 2018
Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patientsMeinolf Suttorp, Markus Metzler, Frederic Millot, et al.
Pageof 59